( in millions, except per share amounts ) |
| Years Ended | 1996 |
1995 |
1994 |
1993 |
1992 |
|
| Net sales |
||||||
| Net income (loss) |
$ 185.4 | $ 264.2 | $ 264.0 | $ 130.3 | ||
| - Primary | $ 1.36 | $ 2.02 | $ 2.02 | $ 0.98 | $ (1.24) | |
| - Fully diluted | $ 1.34 | $ 1.92 | $ 1.87 | $ 0.98 | ($ 1.24) | |
| - Primary | 132.5 | 125.2 | 121.4 | 115.9 | 104.6 | |
| - Fully diluted | 138.6 | 137.5 | 141.4 | 115.9 | 104.6 | |
Research & development expense |
$ 361.3 |
$ 283.1 |
$ 257.8 |
$ 229.2 |
$ 208.9 |
|
| Capital additions | $ 628.1 | $ 476.8 | $ 270.7 | $ 235.1 | $ 189.4 | |
| Current ratio | 1.86 | 1.72 | 1.76 | 1.67 | 1.26 | |
| Debt-to-equity ratio | 23.6% | 7.5% | 2.7% | 5.7% | 8.4% | |
| Number of employees (in thousands) |
20.3 | 22.4 | 22.3 | 23.4 | 27.2 | |
![]() |
![]() |
![]() |